When you search for The Lockwood Group LLC, you’re actually hitting a bit of a digital fork in the road. Most people don’t realize there are actually two very different, very successful companies sharing almost the exact same name. One is a powerhouse in the world of high-stakes medical communications for Big Pharma. The other is a family-founded defense contractor that makes sure the military is "mission ready."
It’s confusing. Honestly, even some industry databases mix them up.
If you're looking for the one that deals with clinical trials, oncology breakthroughs, and those slick medical animations you see at conferences, you’re looking for the Stamford, Connecticut-based agency. Founded in 2007 by Matthew Schecter, this version of The Lockwood Group LLC has basically become the "go-to" partner for pharmaceutical and biotech giants.
They don't just "make slides." They translate incredibly dense science into something a doctor or a payer actually cares about.
Why The Lockwood Group LLC Isn't Just Another Agency
The medical communications world is crowded. It’s full of agencies claiming they "do science." But Lockwood carved out a niche by being hyper-specialized. They aren't generalists. They don't do consumer ads for toothpaste.
Instead, they focus on the "heavy" stuff:
- Medical Affairs: Helping drug companies talk to top-tier doctors (KOLs).
- Publications: Getting clinical trial data into the right journals without the usual headaches.
- Regulatory Consulting: Navigating the nightmare that is FDA or EMA approval.
- Market Access: Making sure insurance companies actually agree to pay for a new drug.
One of the coolest things they’ve done lately was acquiring Random42. If you’ve ever seen a 3D animation of a cell receptor being "unlocked" by a drug molecule—the kind that looks like a Pixar movie but for biology—that’s often Random42. By folding them into The Lockwood Group LLC, they turned boring data into a cinematic experience.
The "Other" Lockwood Group
Now, just to clear the air: if you’re a government contractor or in the military, you might be thinking of the other The Lockwood Group LLC. This one is based in Belcamp, Maryland (with roots in McLean, VA).
This version was founded by James and Jim Lockwood around 2009/2010. They are a Service-Disabled Veteran-Owned Small Business (SDVOSB). Their world isn't about pharmaceutical launches; it’s about C4ISR RESET efforts, logistics for the Army, and engineering services. They’ve pulled in over $67 million in federal contracts.
Two companies. Same name. Totally different "missions."
The Secret Sauce: Culture and Private Equity
Back to the medical side. You've probably noticed that most big agencies eventually get swallowed by giant holding companies and lose their soul. Lockwood tried to dodge that bullet.
In 2021, they took a strategic investment from Ares Management. It wasn't a total sell-out. Matthew Schecter stayed on as CEO. The idea was to keep the "small agency feel" but with the bank account of a global player.
It seems to be working. They’ve been named a "Best Place to Work" by Medical, Marketing and Media (MM&M) multiple times. They have about 600 employees now. That’s huge for a specialized agency. They’ve also been buying up other firms like IDEOlogy Health and Research To Practice (RTP) to dominate the oncology education space.
What Makes Their Approach Different?
Most agencies are reactive. You give them a brief, they give you a deck. Lockwood operates more like an "extension of the team."
kinda annoying? Maybe.
But in the pharma world, where a single mistake in a clinical manuscript can cost millions or delay a launch by six months, that level of "in your business" is exactly what clients pay for. They use something they call the AIMED Method™ for publications. It’s a way of using non-generative AI to track where a doctor’s eye actually goes on a scientific poster.
It’s science for the sake of selling science.
Real-World Impact: Oncology and Rare Diseases
If you look at their recent moves, it’s clear where the money is: Oncology.
The acquisition of Research To Practice (RTP) in late 2025 was a massive signal. RTP has been around for 40 years, founded by Dr. Neil Love. They are the kings of continuing medical education (CME) for cancer docs. By bringing them under the Lockwood umbrella, The Lockwood Group LLC now owns the entire pipeline—from the moment a drug is being tested in a lab to the moment a community oncologist in Ohio learns how to prescribe it.
Actionable Insights for Partners and Talent
If you’re looking to work with them or for them, here’s the ground truth:
- Check the location first: If you're in pharma, look for the Stamford, CT address. If you're in defense, it's Belcamp, MD.
- Specialization is key: Don't go to the medical Lockwood for a "general" marketing campaign. They are scientists first. Most of their account leads have PhDs or PharmDs.
- Expect aggressive growth: Since the Ares investment, they are on an acquisition tear. If you're a smaller agency in the medical space, they might be knocking on your door soon.
- Remote-friendly but high-pressure: They offer great work-life balance (they brag about it in their recruiting), but the nature of medical communications is "deadline or bust."
The Lockwood Group LLC has managed to stay relevant by leaning into the "hard" side of healthcare. While other agencies are trying to figure out TikTok, Lockwood is busy explaining how a CAR-T cell therapy works at a molecular level. That's a much harder moat to cross.
To stay updated on their latest mergers or to see if their scientific storytelling fits your brand's lifecycle, your best bet is to follow their primary portal at thelockwoodgrp.com for the medical side or thelockwoodgroupllc.com for the defense side. Keeping those two URLs straight is half the battle.
Next Steps:
- Audit your current medical communications: Are you using "generalist" agencies for complex therapeutic areas?
- Review your publication strategy: Check if your current agency uses data-driven layout tools like the AIMED Method to ensure your posters actually get read at congresses.
- Verify your vendor: Double-check your procurement records to ensure you aren't confusing the medical and defense entities during the onboarding process.